positionForPages[208]={page:208,positions:[{w:"200",p:[0.083912,0.957873,0.109686,0.957873,0.109686,0.938882,0.083912,0.938882,0.008591,0.008591,0.008591]},{w:"ADDENDUM",p:[0.117647,0.067543,0.201421,0.067543,0.201421,0.045457,0.117647,0.045457,0.009679,0.010295,0.010295,0.008697,0.010706,0.010295,0.010226,0.013582]},{w:"10, 4661–4669 (2004).",p:[0.155000,0.119718,0.326761,0.119718,0.326761,0.101197,0.155000,0.101197,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"298. Nakayama, K. ",p:[0.117647,0.140297,0.268760,0.140297,0.268760,0.121776,0.117647,0.121776,0.009483,0.009483,0.009483,0.004088,0.004814,0.014132,0.008550,0.009650,0.008114,0.008840,0.008259,0.015979,0.008446,0.004088,0.006661,0.013219,0.004088,0.003735]},{w:"et al.",p:[0.271695,0.140297,0.309816,0.140297,0.309816,0.121585,0.271695,0.121585,0.007346,0.005727,0.006807,0.009048,0.004607,0.004586]},{w:" Copper-transporting P-type adenosine triphosphatase (ATP7B) as a ",p:[0.309822,0.140297,0.856644,0.140297,0.856644,0.121776,0.309822,0.121776,0.006661,0.013634,0.009836,0.010044,0.010459,0.008218,0.006578,0.006848,0.005852,0.007178,0.008261,0.010563,0.006827,0.010457,0.009859,0.007240,0.005852,0.005105,0.010417,0.008965,0.006661,0.009629,0.006848,0.005852,0.008840,0.010457,0.008218,0.006661,0.008446,0.010293,0.008218,0.010542,0.009961,0.006910,0.005105,0.010542,0.008218,0.006661,0.005852,0.007097,0.004794,0.010148,0.010272,0.009961,0.006827,0.010148,0.010357,0.008010,0.005954,0.008446,0.007159,0.008218,0.006661,0.006308,0.012285,0.012140,0.011061,0.009483,0.011496,0.006308,0.006661,0.008446,0.006973,0.006661,0.008446,0.003735]},{w:"cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with ",p:[0.155000,0.160875,0.856614,0.160875,0.856614,0.142355,0.155000,0.142355,0.008176,0.005105,0.006827,0.010148,0.004939,0.008010,0.005852,0.005105,0.010687,0.006225,0.010106,0.008446,0.007159,0.008280,0.010355,0.006225,0.007969,0.010272,0.008218,0.015896,0.009859,0.006765,0.008218,0.006910,0.005105,0.006827,0.005954,0.008259,0.010544,0.008176,0.008218,0.006225,0.015979,0.008259,0.006910,0.009338,0.008218,0.007097,0.006225,0.005105,0.010687,0.006225,0.009878,0.008944,0.008259,0.007097,0.005271,0.008259,0.010687,0.006225,0.008280,0.008259,0.006765,0.008176,0.005105,0.010542,0.009857,0.015979,0.008446,0.004088,0.006225,0.008176,0.009857,0.015709,0.010334,0.008259,0.007180,0.008010,0.005852,0.005043,0.008757,0.008218,0.006225,0.008259,0.010625,0.008550,0.004711,0.008840,0.006910,0.005105,0.006973,0.006225,0.013385,0.004794,0.006018,0.010417,0.003735]},{w:"expression of MDR1, MRP1, MRP2, LRP and BCRP. Int. J. Cancer 101, 488–495 (2002).",p:[0.155000,0.181454,0.826910,0.181454,0.826910,0.162933,0.155000,0.162933,0.008280,0.009172,0.010065,0.006765,0.008218,0.006848,0.006910,0.005043,0.009857,0.010687,0.003735,0.009857,0.005644,0.003735,0.017826,0.014339,0.012160,0.009483,0.004088,0.003735,0.017826,0.012160,0.011061,0.009483,0.004088,0.003735,0.017826,0.012160,0.011061,0.009483,0.004088,0.003735,0.010563,0.012160,0.011061,0.003735,0.008255,0.010542,0.010355,0.003735,0.011870,0.013343,0.012160,0.008010,0.004088,0.003735,0.006267,0.010355,0.005852,0.004088,0.003735,0.005103,0.004088,0.003735,0.013613,0.008259,0.010542,0.008176,0.008218,0.007097,0.003735,0.009483,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"299. Hegde, G. V. ",p:[0.117647,0.202033,0.254587,0.202033,0.254587,0.183512,0.117647,0.183512,0.009483,0.009483,0.009483,0.004088,0.004814,0.014734,0.008218,0.008778,0.010293,0.007948,0.004088,0.004462,0.014256,0.004088,0.004462,0.010438,0.004088,0.003735]},{w:"et al.",p:[0.255330,0.202033,0.291209,0.202033,0.291209,0.183321,0.255330,0.183321,0.007346,0.005727,0.004565,0.009048,0.004607,0.004586]},{w:" Blocking NRG1 and other ligand-mediated Her4 signaling enhances the ",p:[0.291209,0.202033,0.856623,0.202033,0.856623,0.183512,0.291209,0.183512,0.004462,0.011268,0.004711,0.010251,0.007969,0.009733,0.005105,0.010417,0.008965,0.004462,0.014754,0.012098,0.014256,0.009483,0.004462,0.008259,0.010542,0.010355,0.004462,0.009834,0.006018,0.010272,0.008218,0.007097,0.004462,0.004773,0.005105,0.008965,0.008259,0.010542,0.010355,0.006848,0.015896,0.008280,0.010355,0.005269,0.008012,0.005644,0.008278,0.010355,0.004462,0.014734,0.008218,0.007097,0.009483,0.004462,0.006910,0.005105,0.008965,0.010625,0.008550,0.004773,0.005105,0.010417,0.008965,0.004462,0.008218,0.010791,0.010355,0.008259,0.010542,0.008176,0.008218,0.006973,0.004462,0.006016,0.010272,0.008218,0.003735]},{w:"magnitude and duration of the chemotherapeutic response of non-small cell lung cancer. Sci. ",p:[0.155000,0.222612,0.856612,0.222612,0.856612,0.204091,0.155000,0.204091,0.015979,0.008363,0.008965,0.010687,0.004794,0.005603,0.010314,0.010293,0.008218,0.002988,0.008259,0.010542,0.010355,0.002988,0.010044,0.010376,0.007180,0.008010,0.005852,0.005043,0.009857,0.010687,0.002988,0.009857,0.005644,0.002988,0.006018,0.010272,0.008218,0.002988,0.007969,0.010272,0.008218,0.015896,0.009836,0.006018,0.010272,0.008218,0.007180,0.008010,0.010459,0.008301,0.010065,0.005852,0.005043,0.008176,0.002988,0.006765,0.008218,0.006827,0.010459,0.009857,0.010563,0.007159,0.008218,0.002988,0.009857,0.005644,0.002988,0.010542,0.009859,0.010687,0.006848,0.006908,0.015979,0.008550,0.004897,0.004773,0.002988,0.008176,0.008135,0.004897,0.004773,0.002988,0.004462,0.010376,0.010417,0.008965,0.002988,0.008280,0.008259,0.010542,0.008176,0.008218,0.005686,0.004088,0.002988,0.009629,0.008176,0.004856,0.004088,0.003735]},{w:"Transl. Med. 5, 171ra18 (2013).",p:[0.155000,0.243190,0.392604,0.243190,0.392604,0.224669,0.155000,0.224669,0.010210,0.007180,0.008259,0.010563,0.006869,0.004524,0.004088,0.003735,0.017245,0.008280,0.010106,0.004088,0.003735,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.007178,0.008446,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"300. Shang, Z.-F. ",p:[0.117647,0.263769,0.248112,0.263769,0.248112,0.245248,0.117647,0.245248,0.009483,0.009483,0.009483,0.004088,0.004814,0.008923,0.010355,0.008259,0.010417,0.008799,0.004088,0.003818,0.011787,0.004088,0.006848,0.007906,0.004088,0.003735]},{w:"et al.",p:[0.248210,0.263769,0.283434,0.263769,0.283434,0.245057,0.248210,0.245057,0.007346,0.005727,0.003910,0.009048,0.004607,0.004586]},{w:" 4E-BP1 participates in maintaining spindle integrity and genomic stability ",p:[0.283434,0.263769,0.856612,0.263769,0.856612,0.245248,0.283434,0.245248,0.003818,0.009483,0.010998,0.006848,0.011328,0.011061,0.009483,0.003818,0.010334,0.008259,0.007242,0.005852,0.005043,0.008176,0.004794,0.010334,0.008010,0.005644,0.008218,0.006973,0.003818,0.005105,0.010687,0.003818,0.015979,0.008259,0.005105,0.010355,0.005956,0.008259,0.005105,0.010687,0.005105,0.010417,0.008965,0.003818,0.006827,0.010065,0.005105,0.010542,0.010480,0.004711,0.008218,0.003818,0.005105,0.010355,0.005644,0.008218,0.008965,0.007097,0.004794,0.005852,0.008840,0.003818,0.008259,0.010542,0.010355,0.003818,0.008778,0.008218,0.010542,0.009857,0.016041,0.005043,0.008176,0.003818,0.006827,0.005956,0.008280,0.009836,0.005229,0.004773,0.004794,0.005852,0.008840,0.003735]},{w:"via interacting with PLK1. Cell Cycle 11, 3463–3471 (2012).",p:[0.155000,0.284348,0.612175,0.284348,0.612175,0.265827,0.155000,0.265827,0.008944,0.005271,0.008446,0.003735,0.005105,0.010355,0.005644,0.008218,0.007180,0.008446,0.008278,0.005852,0.005105,0.010417,0.008965,0.003735,0.013385,0.004794,0.006018,0.010417,0.003735,0.010604,0.010563,0.013219,0.009483,0.004088,0.003735,0.013632,0.008135,0.004897,0.004773,0.003735,0.013219,0.008653,0.007969,0.004711,0.008218,0.003735,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"301. Del Bufalo, D. ",p:[0.117647,0.304926,0.264359,0.304926,0.264359,0.286406,0.117647,0.286406,0.009483,0.009483,0.009483,0.004088,0.004814,0.014754,0.008135,0.004773,0.003030,0.011372,0.010376,0.005644,0.008548,0.004713,0.009336,0.004088,0.003030,0.013738,0.004088,0.003735]},{w:"et al.",p:[0.263660,0.304926,0.298066,0.304926,0.298066,0.286214,0.263660,0.286214,0.007346,0.005727,0.003092,0.009048,0.004607,0.004586]},{w:" Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced ",p:[0.298072,0.304926,0.856660,0.304926,0.856660,0.286406,0.298072,0.286406,0.003030,0.010998,0.010542,0.010293,0.009836,0.006018,0.010272,0.008135,0.004773,0.005105,0.010687,0.006848,0.009483,0.003030,0.010065,0.006765,0.009836,0.005644,0.008278,0.008280,0.005852,0.006973,0.003030,0.009878,0.008944,0.008259,0.007097,0.005271,0.008259,0.010687,0.003030,0.008280,0.008259,0.006765,0.008176,0.005105,0.010542,0.009857,0.015979,0.008446,0.003030,0.008176,0.008135,0.004897,0.004773,0.006973,0.003030,0.008363,0.008965,0.008259,0.005105,0.010563,0.006827,0.005852,0.003030,0.010334,0.008446,0.007969,0.004773,0.004794,0.005956,0.008446,0.008985,0.008135,0.004773,0.006848,0.005105,0.010542,0.010042,0.010316,0.008176,0.008278,0.010355,0.003735]},{w:"apoptosis: requirement for Akt activation. Mol. Pharmacol. 61, 524–532 (2002).",p:[0.155000,0.325505,0.761360,0.325505,0.761360,0.306984,0.155000,0.306984,0.008010,0.010459,0.009836,0.010044,0.005644,0.009961,0.006910,0.005105,0.006973,0.004088,0.003735,0.006765,0.008278,0.009733,0.010376,0.005105,0.006765,0.008218,0.015896,0.008218,0.010355,0.005852,0.003735,0.005478,0.009857,0.007097,0.003735,0.013696,0.009338,0.005852,0.003735,0.008446,0.008280,0.005852,0.005043,0.008944,0.008010,0.005852,0.005043,0.009857,0.010687,0.004088,0.003735,0.017245,0.009940,0.004524,0.004088,0.003735,0.010747,0.010357,0.008259,0.007097,0.015979,0.008446,0.008176,0.009940,0.004524,0.004088,0.003735,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"302. Liu, R. ",p:[0.117647,0.346084,0.208913,0.346084,0.208913,0.327563,0.117647,0.327563,0.009483,0.009483,0.009483,0.004088,0.004814,0.010666,0.004794,0.010127,0.004088,0.003964,0.012451,0.004088,0.003735]},{w:"et al.",p:[0.209150,0.346084,0.244521,0.346084,0.244521,0.327372,0.209150,0.327372,0.007346,0.005727,0.004057,0.009048,0.004607,0.004586]},{w:" The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells har-",p:[0.244520,0.346084,0.852941,0.346084,0.852941,0.327563,0.244520,0.327563,0.003964,0.010428,0.010282,0.008218,0.003964,0.013696,0.009338,0.005852,0.006848,0.006827,0.010459,0.008280,0.008176,0.005105,0.005167,0.005103,0.008176,0.003964,0.005105,0.010789,0.010417,0.005043,0.009838,0.004792,0.005644,0.009857,0.007097,0.003964,0.017826,0.013219,0.009483,0.009483,0.009483,0.009483,0.003964,0.007159,0.008135,0.004711,0.008280,0.008280,0.005852,0.005043,0.008757,0.008135,0.004711,0.008840,0.003964,0.005105,0.010789,0.010417,0.005043,0.009836,0.004794,0.005852,0.006973,0.003964,0.006018,0.010065,0.008840,0.006765,0.009857,0.005043,0.010355,0.003964,0.008280,0.008259,0.010542,0.008176,0.008218,0.007097,0.003964,0.008176,0.008135,0.004897,0.004773,0.006973,0.003964,0.010355,0.008259,0.006630,0.006848]},{w:"boring mutations that can activate the PI3K/Akt pathway. J. Clin. Endocrinol. Metab. 96, ",p:[0.155000,0.366663,0.856633,0.366663,0.856633,0.348142,0.155000,0.348142,0.010231,0.009857,0.007097,0.005105,0.010417,0.008965,0.005852,0.015709,0.010065,0.005956,0.008010,0.005852,0.005043,0.009857,0.010563,0.006973,0.005852,0.006018,0.010357,0.008008,0.005852,0.005852,0.008280,0.008259,0.010687,0.005852,0.008446,0.008280,0.005852,0.005043,0.008944,0.008010,0.005644,0.008218,0.005852,0.006018,0.010272,0.008218,0.005852,0.010604,0.006599,0.009483,0.013219,0.006454,0.013694,0.009340,0.005852,0.005852,0.010334,0.008010,0.006018,0.010065,0.013385,0.008114,0.007263,0.004088,0.005852,0.005105,0.004088,0.005852,0.013406,0.004773,0.005105,0.010687,0.004088,0.005852,0.010998,0.010542,0.010293,0.010251,0.008176,0.007097,0.005105,0.010542,0.009940,0.004524,0.004088,0.005852,0.017245,0.008301,0.005956,0.008280,0.009317,0.004088,0.005852,0.009483,0.009483,0.004088,0.003735]},{w:"E577–85 (2011).",p:[0.155000,0.387241,0.282519,0.387241,0.282519,0.368720,0.155000,0.368720,0.010998,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"303. Aqeilan, R. I. ",p:[0.117647,0.407820,0.261414,0.407820,0.261414,0.389299,0.117647,0.389299,0.009483,0.009483,0.009483,0.004088,0.004814,0.013032,0.010085,0.008218,0.005229,0.004937,0.008261,0.010687,0.004088,0.005458,0.012451,0.004088,0.005458,0.006599,0.004088,0.003735]},{w:"et al.",p:[0.263119,0.407820,0.300014,0.407820,0.300014,0.389108,0.263119,0.389108,0.007346,0.005727,0.005582,0.009046,0.004607,0.004586]},{w:" Targeted deletion of Wwox reveals a tumor suppressor function. Proc. ",p:[0.300006,0.407820,0.856731,0.407820,0.856731,0.389299,0.300006,0.389299,0.005458,0.009919,0.008259,0.006931,0.008778,0.008301,0.005644,0.008280,0.010355,0.005458,0.010293,0.008135,0.004711,0.008301,0.005852,0.005043,0.009857,0.010687,0.005458,0.009859,0.005644,0.005458,0.017763,0.013198,0.009836,0.009172,0.005458,0.006765,0.008485,0.008757,0.008446,0.008550,0.004773,0.006973,0.005458,0.008446,0.005458,0.005603,0.010376,0.015896,0.009857,0.007097,0.005458,0.006827,0.010065,0.010044,0.010065,0.006765,0.008218,0.006848,0.007159,0.009857,0.007097,0.005458,0.005790,0.010376,0.010542,0.008280,0.005852,0.005043,0.009857,0.010687,0.004088,0.005458,0.010834,0.006765,0.010249,0.008176,0.004088,0.003735]},{w:"Natl. Acad. Sci. U. S. A. 104, 3949–3954 (2007).",p:[0.155000,0.428399,0.513793,0.428399,0.513793,0.409878,0.155000,0.409878,0.014132,0.008010,0.006018,0.004524,0.004088,0.003735,0.013032,0.008280,0.008446,0.010106,0.004088,0.003735,0.009627,0.008176,0.004856,0.004088,0.003735,0.012638,0.004088,0.003735,0.009193,0.004088,0.003735,0.013572,0.004088,0.003735,0.009483,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"304. Schirmer, M. A. ",p:[0.117647,0.448977,0.279966,0.448977,0.279966,0.430456,0.117647,0.430456,0.009483,0.009483,0.009483,0.004088,0.004814,0.009629,0.007969,0.010417,0.005105,0.007097,0.015896,0.008218,0.005686,0.004088,0.003777,0.017826,0.004088,0.003777,0.013572,0.004088,0.003735]},{w:"et al.",p:[0.280021,0.448977,0.315195,0.448977,0.315195,0.430265,0.280021,0.430265,0.007346,0.005727,0.003860,0.009048,0.004607,0.004586]},{w:" Relevance of Sp Binding Site Polymorphism in WWOX for Treatment ",p:[0.315200,0.448977,0.856632,0.448977,0.856632,0.430456,0.315200,0.430456,0.003777,0.012451,0.008135,0.004711,0.008487,0.008944,0.008259,0.010542,0.008176,0.008218,0.003777,0.009859,0.005644,0.003777,0.008902,0.010251,0.003777,0.011351,0.005105,0.010542,0.010355,0.005105,0.010417,0.008965,0.003777,0.009193,0.004794,0.005644,0.008218,0.003777,0.010148,0.009940,0.004711,0.008840,0.015896,0.009857,0.007242,0.010148,0.010417,0.005105,0.006910,0.016041,0.003777,0.005105,0.010687,0.003777,0.019091,0.018427,0.014236,0.012825,0.003777,0.005478,0.009857,0.007097,0.003777,0.010210,0.006765,0.008446,0.008010,0.005852,0.015896,0.008218,0.010355,0.005852,0.003735]},{w:"Outcome in Pancreatic Cancer. J. Natl. Cancer Inst. 108, (2016).",p:[0.155000,0.469556,0.638137,0.469556,0.638137,0.451035,0.155000,0.451035,0.015003,0.010065,0.005644,0.008176,0.009857,0.015896,0.008218,0.003735,0.005105,0.010687,0.003735,0.010376,0.008259,0.010542,0.008176,0.006765,0.008446,0.008010,0.005852,0.005043,0.008176,0.003735,0.013611,0.008261,0.010542,0.008176,0.008218,0.005686,0.004088,0.003735,0.005103,0.004088,0.003735,0.014132,0.008010,0.006018,0.004524,0.004088,0.003735,0.013613,0.008259,0.010542,0.008176,0.008218,0.007097,0.003735,0.006267,0.010563,0.006827,0.005852,0.004088,0.003735,0.009483,0.009483,0.009483,0.004088,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"305. Bunn, P. A., Jr ",p:[0.117647,0.490135,0.263323,0.490135,0.263323,0.471614,0.117647,0.471614,0.009483,0.009483,0.009483,0.004088,0.004814,0.011372,0.010376,0.010687,0.010687,0.004088,0.003611,0.008010,0.004088,0.003611,0.013572,0.004088,0.004088,0.003611,0.005603,0.007097,0.003735]},{w:"et al.",p:[0.263210,0.490135,0.298218,0.490135,0.298218,0.471423,0.263210,0.471423,0.007346,0.005727,0.003694,0.009048,0.004607,0.004586]},{w:" Expression of Her-2/neu in human lung cancer cell lines by immunohis-",p:[0.298218,0.490135,0.852941,0.490135,0.852941,0.471614,0.298218,0.471614,0.003611,0.011059,0.009172,0.010065,0.006765,0.008218,0.006848,0.006910,0.005043,0.009857,0.010687,0.003611,0.009857,0.005644,0.003611,0.014734,0.008218,0.006578,0.006848,0.009483,0.006454,0.010542,0.008301,0.010376,0.003611,0.005105,0.010687,0.003611,0.010085,0.010376,0.015979,0.008259,0.010687,0.003611,0.004462,0.010376,0.010417,0.008965,0.003611,0.008280,0.008259,0.010542,0.008176,0.008218,0.007097,0.003611,0.008176,0.008135,0.004897,0.004773,0.003611,0.004773,0.005105,0.010542,0.008218,0.006973,0.003611,0.009857,0.008840,0.003611,0.005105,0.016041,0.015709,0.010376,0.010542,0.009940,0.010417,0.005105,0.007007,0.006848]},{w:"tochemistry and fluorescence in situ hybridization and its relationship to ",p:[0.155000,0.510713,0.707321,0.510713,0.707321,0.492193,0.155000,0.492193,0.005644,0.010251,0.007969,0.010272,0.008218,0.016041,0.005105,0.006827,0.005852,0.007637,0.008840,0.003300,0.008259,0.010542,0.010355,0.003300,0.005126,0.004814,0.010314,0.009857,0.006765,0.008218,0.007157,0.008176,0.008218,0.010542,0.008176,0.008218,0.003300,0.005105,0.010687,0.003300,0.006910,0.004794,0.005603,0.010376,0.003300,0.010065,0.009089,0.009836,0.007097,0.005043,0.010355,0.005105,0.008031,0.008010,0.005852,0.005041,0.009859,0.010687,0.003300,0.008259,0.010542,0.010355,0.003300,0.004792,0.005852,0.006973,0.003300,0.006765,0.008135,0.004939,0.008010,0.005852,0.005043,0.009857,0.010563,0.006869,0.010417,0.004794,0.010251,0.003300,0.005644,0.010044,0.003735]},{w:"in vitro",p:[0.706969,0.510713,0.759429,0.510713,0.759429,0.492001,0.706969,0.492001,0.004628,0.010272,0.003383,0.008446,0.004731,0.005333,0.006641,0.009027]},{w:" cytotoxicity ",p:[0.759427,0.510713,0.856669,0.510713,0.856669,0.492193,0.759427,0.492193,0.003300,0.008529,0.008840,0.005644,0.009836,0.005644,0.009836,0.009172,0.005043,0.008176,0.004794,0.005852,0.008840,0.003735]},{w:"by trastuzumab and chemotherapeutic agents. Clin. Cancer Res. 7, 3239–3250 (2001).",p:[0.155000,0.531292,0.810083,0.531292,0.810083,0.512771,0.155000,0.512771,0.009857,0.008840,0.003735,0.005852,0.007180,0.008446,0.006827,0.005603,0.010376,0.008031,0.010376,0.015979,0.008280,0.010023,0.003735,0.008259,0.010542,0.010355,0.003735,0.007969,0.010272,0.008218,0.015896,0.009836,0.006018,0.010272,0.008218,0.007180,0.008010,0.010459,0.008299,0.010067,0.005852,0.005043,0.008176,0.003735,0.008361,0.008778,0.008218,0.010355,0.005852,0.006973,0.004088,0.003735,0.013406,0.004773,0.005105,0.010687,0.004088,0.003735,0.013613,0.008259,0.010542,0.008176,0.008218,0.007097,0.003735,0.012449,0.008218,0.006973,0.004088,0.003735,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"306. Kimura, K. ",p:[0.117647,0.551871,0.245633,0.551871,0.245633,0.533350,0.117647,0.533350,0.009483,0.009483,0.009483,0.004088,0.004814,0.013157,0.005105,0.015709,0.010376,0.007180,0.008446,0.004088,0.005530,0.013219,0.004088,0.003735]},{w:"et al.",p:[0.247427,0.551871,0.284385,0.551871,0.284385,0.533159,0.247427,0.533159,0.007346,0.005727,0.005644,0.009048,0.004607,0.004586]},{w:" Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 ",p:[0.284393,0.551871,0.856675,0.551871,0.856675,0.533350,0.284393,0.533350,0.005530,0.013572,0.010355,0.005852,0.004794,0.005603,0.010376,0.015896,0.009857,0.007097,0.005530,0.008218,0.005427,0.005261,0.008280,0.008278,0.005852,0.005530,0.009857,0.005644,0.005530,0.005852,0.007180,0.008446,0.006827,0.005603,0.010376,0.008031,0.010376,0.015979,0.008280,0.010023,0.005530,0.005478,0.009857,0.007097,0.005530,0.010334,0.008259,0.010542,0.008176,0.006765,0.008446,0.008010,0.005852,0.005043,0.008176,0.005528,0.008280,0.008259,0.010544,0.008176,0.008218,0.007097,0.005528,0.013385,0.004794,0.006018,0.010417,0.005530,0.010417,0.005105,0.009027,0.010417,0.005528,0.015315,0.010998,0.011227,0.006848,0.009483,0.003735]},{w:"expression and enhancement of effect by combined therapy with gemcitabine. Clin. Cancer ",p:[0.155000,0.572450,0.856731,0.572450,0.856731,0.553929,0.155000,0.553929,0.008280,0.009172,0.010065,0.006765,0.008218,0.006848,0.006910,0.005043,0.009857,0.010687,0.003984,0.008259,0.010542,0.010355,0.003984,0.008218,0.010791,0.010355,0.008259,0.010542,0.008176,0.008218,0.015896,0.008218,0.010355,0.005852,0.003984,0.009857,0.005644,0.003984,0.008218,0.005427,0.005261,0.008280,0.008280,0.005852,0.003984,0.009855,0.008840,0.003984,0.008176,0.009857,0.015813,0.009836,0.005105,0.010542,0.008280,0.010355,0.003984,0.006018,0.010272,0.008218,0.007178,0.008012,0.010083,0.008840,0.003984,0.013385,0.004794,0.006016,0.010417,0.003984,0.008778,0.008218,0.015896,0.008176,0.004794,0.005956,0.008280,0.009836,0.005105,0.010542,0.007948,0.004088,0.003984,0.013406,0.004773,0.005105,0.010687,0.004088,0.003984,0.013611,0.008259,0.010544,0.008176,0.008218,0.007097,0.003735]},{w:"Res. 12, 4925–4932 (2006).",p:[0.155000,0.593028,0.362226,0.593028,0.362226,0.574507,0.155000,0.574507,0.012451,0.008218,0.006973,0.004088,0.003735,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"307. Stankova, J., Shang, J. \& Rozen, R. Antisense inhibition of methylenetetrahydrofolate re-",p:[0.117647,0.613607,0.852941,0.613607,0.852941,0.595086,0.117647,0.595086,0.009483,0.009483,0.009483,0.004088,0.004814,0.008902,0.005956,0.008259,0.010791,0.009338,0.009878,0.008944,0.008446,0.004088,0.006402,0.005105,0.004088,0.004088,0.006400,0.008923,0.010355,0.008261,0.010417,0.008799,0.004088,0.006400,0.005107,0.004088,0.006400,0.014298,0.006402,0.012451,0.009940,0.008031,0.008218,0.010687,0.004088,0.006400,0.012451,0.004088,0.006402,0.013572,0.010355,0.005852,0.005105,0.007159,0.008218,0.010563,0.007159,0.008218,0.006400,0.005105,0.010791,0.010417,0.005043,0.009836,0.004794,0.005852,0.005043,0.009857,0.010687,0.006402,0.009857,0.005644,0.006402,0.015896,0.008301,0.006018,0.010065,0.008900,0.004711,0.008218,0.010544,0.008299,0.005647,0.008299,0.005852,0.007180,0.008550,0.010065,0.008653,0.010355,0.006765,0.009857,0.005478,0.009940,0.004939,0.008010,0.005644,0.008218,0.006402,0.006765,0.008217,0.006848]},{w:"ductase reduces cancer cell survival ",p:[0.155000,0.634186,0.430164,0.634186,0.430164,0.615665,0.155000,0.615665,0.010044,0.010314,0.008280,0.005956,0.008446,0.007159,0.008218,0.004150,0.006765,0.008280,0.010044,0.010314,0.008176,0.008218,0.006973,0.004150,0.008280,0.008259,0.010542,0.008176,0.008218,0.007097,0.004150,0.008176,0.008135,0.004897,0.004773,0.004150,0.006827,0.010376,0.007635,0.008944,0.005043,0.008944,0.008550,0.004773,0.003735]},{w:"in vitro",p:[0.430576,0.634186,0.483887,0.634186,0.483887,0.615474,0.430576,0.615474,0.004628,0.010272,0.004233,0.008446,0.004731,0.005333,0.006641,0.009027]},{w:" and tumor growth ",p:[0.483894,0.634186,0.633492,0.634186,0.633492,0.615665,0.483894,0.615665,0.004150,0.008259,0.010542,0.010355,0.004150,0.005603,0.010376,0.015896,0.009857,0.007097,0.004150,0.008965,0.006765,0.009878,0.013385,0.006018,0.010417,0.003735]},{w:"in vivo",p:[0.633905,0.634186,0.683501,0.634186,0.683501,0.615474,0.633905,0.615474,0.004628,0.010272,0.004233,0.008446,0.004690,0.008301,0.009027]},{w:". Clin. Cancer Res. 11, ",p:[0.683509,0.634186,0.856680,0.634186,0.856680,0.615665,0.683509,0.615665,0.004088,0.004150,0.013403,0.004773,0.005105,0.010687,0.004088,0.004150,0.013611,0.008259,0.010544,0.008176,0.008218,0.007097,0.004150,0.012451,0.008218,0.006973,0.004088,0.004150,0.009483,0.009483,0.004088,0.003735]},{w:"2047–2052 (2005).",p:[0.155000,0.654764,0.299971,0.654764,0.299971,0.636244,0.155000,0.636244,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"308. McCluggage, W. G. ",p:[0.117647,0.675343,0.303976,0.675343,0.303976,0.656822,0.117647,0.656822,0.009483,0.009483,0.009483,0.004088,0.004814,0.017245,0.008176,0.013406,0.004462,0.010376,0.009068,0.008965,0.008361,0.008778,0.007950,0.004088,0.003061,0.015813,0.004088,0.003061,0.014256,0.004088,0.003735]},{w:"et al.",p:[0.303302,0.675343,0.337750,0.675343,0.337750,0.656631,0.303302,0.656631,0.007346,0.005727,0.003133,0.009048,0.004607,0.004586]},{w:" Data set for reporting of ovary, fallopian tube and primary peritone-",p:[0.337746,0.675343,0.852941,0.675343,0.852941,0.656822,0.337746,0.656822,0.003061,0.014734,0.008010,0.005956,0.008446,0.003061,0.007159,0.008301,0.005852,0.003071,0.005476,0.009857,0.007097,0.003071,0.006765,0.008301,0.010459,0.009857,0.007242,0.005852,0.005105,0.010417,0.008965,0.003061,0.009857,0.005644,0.003061,0.009878,0.008944,0.008259,0.007637,0.007263,0.004088,0.003061,0.005644,0.008550,0.004897,0.004711,0.009836,0.010065,0.005271,0.008259,0.010687,0.003071,0.005601,0.010316,0.010228,0.008218,0.003071,0.008259,0.010542,0.010355,0.003061,0.010065,0.007097,0.005105,0.015979,0.008259,0.007637,0.008840,0.003061,0.010459,0.008218,0.007097,0.004794,0.005644,0.009857,0.010542,0.008185,0.006848]},{w:"al carcinoma: recommendations from the International Collaboration on Cancer Reporting ",p:[0.155000,0.695922,0.856718,0.695922,0.856718,0.677401,0.155000,0.677401,0.008550,0.004773,0.003466,0.008280,0.008259,0.006765,0.008176,0.005105,0.010542,0.009857,0.015979,0.008446,0.004088,0.003455,0.006765,0.008280,0.008176,0.009857,0.016041,0.015896,0.008218,0.010542,0.010521,0.008010,0.005852,0.005043,0.009857,0.010563,0.006973,0.003466,0.005831,0.006765,0.009857,0.016041,0.003466,0.006018,0.010272,0.008218,0.003455,0.006269,0.010355,0.005644,0.008218,0.007097,0.010625,0.008010,0.005852,0.005043,0.009857,0.010625,0.008550,0.004773,0.003455,0.013634,0.009940,0.004897,0.004939,0.008280,0.010231,0.009857,0.007180,0.008010,0.005852,0.005043,0.009857,0.010687,0.003466,0.009857,0.010687,0.003466,0.013611,0.008259,0.010544,0.008176,0.008218,0.007097,0.003455,0.012451,0.008301,0.010459,0.009857,0.007242,0.005852,0.005105,0.010417,0.008965,0.003735]},{w:"(ICCR). Mod. Pathol. 28, 1101–1122 (2015).",p:[0.155000,0.716500,0.494702,0.716500,0.494702,0.697980,0.155000,0.697980,0.006308,0.006205,0.013406,0.013343,0.012160,0.006308,0.004088,0.003735,0.017243,0.010251,0.010106,0.004088,0.003735,0.010376,0.008010,0.006018,0.010272,0.009940,0.004524,0.004088,0.003735,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"309. Phan, N. ",p:[0.117647,0.737079,0.225576,0.737079,0.225576,0.718558,0.117647,0.718558,0.009483,0.009483,0.009483,0.004088,0.004814,0.010749,0.010355,0.008259,0.010687,0.004088,0.003860,0.014754,0.004088,0.003735]},{w:"et al.",p:[0.225715,0.737079,0.260982,0.737079,0.260982,0.718367,0.225715,0.718367,0.007346,0.005727,0.003953,0.009048,0.004607,0.004586]},{w:" A simple high-throughput approach identifies actionable drug sensitivities in ",p:[0.260981,0.737079,0.856611,0.737079,0.856611,0.718558,0.260981,0.718558,0.003860,0.013572,0.003860,0.006910,0.005105,0.015709,0.010148,0.004711,0.008218,0.003860,0.010417,0.005105,0.009027,0.010417,0.006848,0.006018,0.010417,0.006765,0.009836,0.010376,0.009027,0.010085,0.010044,0.010065,0.005852,0.003860,0.008010,0.010044,0.010065,0.006765,0.010127,0.008446,0.007969,0.010417,0.003860,0.005043,0.010293,0.008218,0.010355,0.005852,0.005105,0.005167,0.005105,0.008218,0.006973,0.003860,0.008446,0.008280,0.005852,0.005043,0.009857,0.010625,0.008280,0.009919,0.004711,0.008218,0.003860,0.010355,0.007240,0.010376,0.008965,0.003860,0.007159,0.008218,0.010563,0.006910,0.004794,0.005852,0.005043,0.008944,0.004792,0.005852,0.005043,0.008218,0.006973,0.003860,0.005105,0.010687,0.003735]},{w:"patient-derived tumor organoids. Commun Biol 2, 78 (2019).",p:[0.155000,0.757658,0.623985,0.757658,0.623985,0.739137,0.155000,0.739137,0.010334,0.008010,0.005852,0.005043,0.008218,0.010355,0.005852,0.006848,0.010293,0.008218,0.007097,0.005043,0.008757,0.008280,0.010355,0.003735,0.005603,0.010376,0.015896,0.009857,0.007097,0.003735,0.009857,0.006929,0.008965,0.008261,0.010542,0.009857,0.005043,0.010355,0.006973,0.004088,0.003735,0.013632,0.009857,0.016041,0.015709,0.010376,0.010687,0.003735,0.011351,0.005043,0.009940,0.004773,0.003735,0.009483,0.004088,0.003735,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"310. Maru, Y., Tanaka, N., Itami, M. \& Hippo, Y. Efficient use of patient-derived organoids as a ",p:[0.117647,0.778237,0.856675,0.778237,0.856675,0.759716,0.117647,0.759716,0.009483,0.009483,0.009483,0.004088,0.004814,0.017348,0.008259,0.007242,0.010127,0.004088,0.005178,0.009566,0.004088,0.004088,0.005175,0.009919,0.008259,0.010627,0.008548,0.009650,0.008446,0.004088,0.005178,0.014754,0.004088,0.004088,0.005178,0.005686,0.005954,0.008261,0.016041,0.004854,0.004088,0.005178,0.017826,0.004088,0.005178,0.014298,0.005178,0.014983,0.004792,0.010044,0.010459,0.009338,0.004088,0.005178,0.009566,0.004088,0.005175,0.010998,0.005174,0.005174,0.005112,0.008176,0.005043,0.008218,0.010355,0.005852,0.005178,0.010376,0.007159,0.008218,0.005178,0.009857,0.005644,0.005178,0.010332,0.008010,0.005852,0.005043,0.008218,0.010355,0.005852,0.006848,0.010293,0.008218,0.007097,0.005043,0.008757,0.008280,0.010355,0.005178,0.009857,0.006931,0.008965,0.008259,0.010542,0.009857,0.005043,0.010355,0.006973,0.005178,0.008446,0.006973,0.005178,0.008446,0.003735]},{w:"preclinical model for gynecologic tumors. Gynecol. Oncol. 154, 189–198 (2019).",p:[0.155000,0.798815,0.768188,0.798815,0.768188,0.780294,0.155000,0.780294,0.010065,0.006765,0.008280,0.007969,0.004773,0.005105,0.010687,0.005043,0.008280,0.008550,0.004773,0.003735,0.015894,0.010251,0.010293,0.008135,0.004773,0.003735,0.005478,0.009857,0.007097,0.003735,0.009587,0.008840,0.010542,0.008280,0.008176,0.009940,0.004711,0.010044,0.008965,0.005043,0.008176,0.003735,0.005603,0.010376,0.015896,0.009857,0.006931,0.006973,0.004088,0.003735,0.014194,0.008840,0.010542,0.008280,0.008176,0.009940,0.004524,0.004088,0.003735,0.014815,0.010544,0.008176,0.009940,0.004524,0.004088,0.003735,0.009483,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"311. Gotimer, K., Chen, H., Leiserowitz, G. S. \& Smith, L. H. Short-term organoid culture for drug ",p:[0.117647,0.819394,0.856689,0.819394,0.856689,0.800873,0.117647,0.800873,0.009483,0.009483,0.009483,0.004088,0.004814,0.014381,0.009836,0.005852,0.005105,0.015896,0.008218,0.005686,0.004088,0.003009,0.013219,0.004088,0.004088,0.003009,0.013406,0.010272,0.008218,0.010687,0.004088,0.003009,0.015315,0.004088,0.004088,0.003009,0.010747,0.008218,0.005105,0.007159,0.008218,0.006765,0.009878,0.013385,0.004794,0.005914,0.008031,0.004088,0.003009,0.014256,0.004088,0.003009,0.009193,0.004088,0.003009,0.014298,0.003009,0.009193,0.016041,0.004794,0.006018,0.010417,0.004088,0.003009,0.010563,0.004088,0.003009,0.015315,0.004088,0.003009,0.008923,0.010272,0.009857,0.007242,0.005852,0.006848,0.005644,0.008218,0.007097,0.016041,0.003009,0.009857,0.006931,0.008965,0.008259,0.010542,0.009857,0.005043,0.010355,0.003009,0.008278,0.010500,0.004462,0.005603,0.010376,0.006765,0.008218,0.003009,0.005478,0.009857,0.007097,0.003009,0.010355,0.007240,0.010376,0.008965,0.003735]},{w:"sensitivity testing in high-grade serous ovarian cancer. Gynecol. Oncol. 154, 92–93 (2019).",p:[0.155000,0.839973,0.842269,0.839973,0.842269,0.821452,0.155000,0.821452,0.007159,0.008218,0.010563,0.006910,0.004794,0.005852,0.005043,0.008944,0.004794,0.005852,0.008840,0.003735,0.005642,0.008218,0.006829,0.005852,0.005105,0.010415,0.008965,0.003735,0.005105,0.010687,0.003735,0.010417,0.005105,0.009027,0.010417,0.006848,0.008965,0.007180,0.008446,0.010293,0.008218,0.003735,0.007157,0.008218,0.006765,0.009836,0.010376,0.006973,0.003735,0.009878,0.008944,0.008259,0.007097,0.005271,0.008259,0.010687,0.003735,0.008280,0.008259,0.010542,0.008176,0.008218,0.005686,0.004088,0.003735,0.014194,0.008840,0.010542,0.008280,0.008176,0.009940,0.004524,0.004088,0.003735,0.014817,0.010542,0.008176,0.009940,0.004524,0.004088,0.003735,0.009483,0.009483,0.009483,0.004088,0.003735,0.009483,0.009483,0.010729,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"312. Tiriac, H. ",p:[0.117647,0.860551,0.234230,0.860551,0.234230,0.842031,0.117647,0.842031,0.009483,0.009483,0.009483,0.004088,0.004814,0.011579,0.005105,0.007097,0.005271,0.008446,0.008176,0.004088,0.006329,0.015315,0.004088,0.003735]},{w:"et al.",p:[0.236820,0.860551,0.274609,0.860551,0.274609,0.841839,0.236820,0.841839,0.007346,0.005727,0.006475,0.009048,0.004607,0.004586]},{w:" Organoid Profiling Identifies Common Responders to Chemotherapy in ",p:[0.274602,0.860551,0.856683,0.860551,0.856683,0.842031,0.274602,0.842031,0.006329,0.014817,0.006931,0.008965,0.008259,0.010542,0.009857,0.005043,0.010355,0.006329,0.010832,0.006765,0.009857,0.005167,0.005292,0.004773,0.005105,0.010417,0.008965,0.006329,0.006016,0.010295,0.008218,0.010355,0.005852,0.005105,0.005167,0.005103,0.008218,0.006973,0.006329,0.013634,0.009857,0.016041,0.015896,0.009857,0.010687,0.006329,0.012451,0.008218,0.006827,0.010459,0.009857,0.010542,0.010293,0.008218,0.006931,0.006973,0.006329,0.005644,0.010044,0.006329,0.013406,0.010272,0.008218,0.015896,0.009836,0.006018,0.010272,0.008218,0.007180,0.008010,0.010085,0.008840,0.006329,0.005105,0.010687,0.003735]},{w:"Pancreatic Cancer. Cancer Discov. 8, 1112–1129 (2018).",p:[0.155000,0.881130,0.582689,0.881130,0.582689,0.862609,0.155000,0.862609,0.010376,0.008259,0.010542,0.008176,0.006765,0.008446,0.008010,0.005852,0.005043,0.008176,0.003735,0.013613,0.008259,0.010542,0.008176,0.008218,0.005686,0.004088,0.003735,0.013611,0.008259,0.010544,0.008176,0.008218,0.007097,0.003735,0.014566,0.005105,0.007159,0.008176,0.009878,0.007367,0.004088,0.003735,0.009483,0.004088,0.003735,0.009483,0.009483,0.009483,0.009483,0.010729,0.009483,0.009483,0.009483,0.009483,0.003735,0.006308,0.009483,0.009483,0.009483,0.009483,0.006308,0.004088]},{w:"313. Saleem, A. \& Price, P. M. Early tumor drug pharmacokinetics is influenced by tumor perfu-",p:[0.117647,0.901709,0.852941,0.901709,0.852941,0.883188,0.117647,0.883188,0.009483,0.009483,0.009483,0.004088,0.004814,0.009193,0.008550,0.004711,0.008280,0.008218,0.016041,0.004088,0.003984,0.013572,0.004088,0.003984,0.014298,0.003984,0.010832,0.007097,0.005043,0.008176,0.007948,0.004088,0.003984,0.008010,0.004088,0.003984,0.017826,0.004088,0.003984,0.011247,0.008259,0.006910,0.004711,0.008840,0.003984,0.005603,0.010376,0.015896,0.009857,0.007097,0.003984,0.010355,0.007240,0.010376,0.008965,0.003984,0.010148,0.010355,0.008259,0.007097,0.015979,0.008446,0.008176,0.009940,0.009733,0.005105,0.010542,0.008301,0.005852,0.005043,0.008176,0.006973,0.003984,0.005105,0.006973,0.003984,0.005105,0.010687,0.005126,0.004814,0.010314,0.008218,0.010542,0.008176,0.008280,0.010355,0.003984,0.009855,0.008840,0.003984,0.005603,0.010376,0.015896,0.009857,0.007097,0.003984,0.010459,0.008218,0.007097,0.005790,0.010444,0.006848]}]};